allantoin has been researched along with Scleroderma, Systemic in 1 studies
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walther, H | 1 |
1 review available for allantoin and Scleroderma, Systemic
| Article | Year |
|---|---|
[On the therapy of skin and veneral diseases. Review of the literature 1965-66].
Topics: Adult; Allantoin; Chloramphenicol; Cortisone; Dimethyl Sulfoxide; Erectile Dysfunction; Frostbite; H | 1968 |